Application | Comment | Organism |
---|---|---|
drug development | enzyme inhibitors may prove to be targets for the generation of agents in the treatment of neutrophilic inflammatory disease | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
(E)-4-(N-(2-(1-(hydroxyimino)butyl)phenyl)sulfamoyl)phenyl pivalate | - |
Homo sapiens | |
(E)-4-(N-(2-(1-(hydroxyimino)ethyl)phenyl)sulfamoyl)phenyl pivalate | the compound has several beneficial effects in inflammatory disease and lipopolysacchride-induced edema, overview | Homo sapiens | |
(E)-4-(N-(2-(1-(hydroxyimino)methyl)phenyl)sulfamoyl)phenyl pivalate | - |
Homo sapiens | |
(E)-4-(N-(2-(1-(hydroxyimino)propyl)phenyl)sulfamoyl)phenyl pivalate | - |
Homo sapiens | |
(E)-4-(N-(2-(1-(methoxyimino)ethyl)phenyl)sulfamoyl)phenyl pivalate | - |
Homo sapiens | |
(Z)-4-(N-(2-(1-(methoxyimino)ethyl)phenyl)sulfamoyl)phenyl pivalate | - |
Homo sapiens | |
2-hydroxyethyl 2-(4-(pivaloyloxy)phenylsulfonamido)benzoate | - |
Homo sapiens | |
4-(N-(2-(2-hydroxyethylcarbamoyl)phenyl)sulfamoyl)phenyl pivalate | - |
Homo sapiens | |
4-(N-(2-acetylphenyl)sulfamoyl)phenyl 2-methylpropane-2-sulfinate | - |
Homo sapiens | |
4-(N-(2-acetylphenyl)sulfamoyl)phenyl pivalate | - |
Homo sapiens | |
4-(N-(2-butyrylphenyl)sulfamoyl)phenyl pivalate | - |
Homo sapiens | |
4-(N-(2-formylphenyl)sulfamoyl)phenyl 2-methylpropane-2-sulfinate | - |
Homo sapiens | |
4-(N-(2-formylphenyl)sulfamoyl)phenyl pivalate | - |
Homo sapiens | |
4-(N-(2-pentanoyl phenyl)sulfamoyl)phenyl pivalate | - |
Homo sapiens | |
4-(N-(2-propionylphenyl)sulfamoyl)phenyl pivalate | - |
Homo sapiens | |
ethyl 2-(4-(3,3,3-trifluoro-2,2-dimethylpropanoyloxy)benzamido)benzoate | - |
Homo sapiens | |
ethyl 2-(4-(pivaloyloxy)benzamido)benzoate | - |
Homo sapiens | |
methyl 2-(4-(3,3,3-trifluoro-2,2-dimethylpropanoyloxy)benzamido)benzoate | - |
Homo sapiens | |
methyl 2-(4-(3,3,3-trifluoro-2,2-dimethylpropanoyloxy)phenylsulfonamide)benzoate | - |
Homo sapiens | |
methyl 2-(4-(pivaloyloxy)benzamido)benzoate | - |
Homo sapiens | |
methyl 2-(4-pivalamidophenylsulfonamido)benzoate | - |
Homo sapiens | |
additional information | synthesis and pharmacological characterization of 2-aminobenzaldehyde oxime analogues as dual inhibitors of neutrophil elastase and proteinase 3, structureactivity relationship analysis, overview | Homo sapiens | |
propyl 2-(4-(3,3,3-trifluoro-2,2-dimethylpropanoyloxy)benzamido)benzoate | - |
Homo sapiens | |
propyl 2-(4-(pivaloyloxy)benzamido)benzoate | - |
Homo sapiens | |
sivelestat | - |
Homo sapiens |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
azurophil granule | a major neutrophilic serine protease expressed in neutrophil azurophil granules | Homo sapiens | 42582 | - |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | P24158 | - |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
neutrophil | - |
Homo sapiens | - |
Synonyms | Comment | Organism |
---|---|---|
PR3 | - |
Homo sapiens |
proteinase 3 | - |
Homo sapiens |
Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|
30 | - |
assay at | Homo sapiens |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
7.4 | - |
assay at | Homo sapiens |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.00022 | - |
pH 7.4, 30°C | Homo sapiens | (E)-4-(N-(2-(1-(hydroxyimino)ethyl)phenyl)sulfamoyl)phenyl pivalate | |
0.00031 | - |
pH 7.4, 30°C | Homo sapiens | 4-(N-(2-(2-hydroxyethylcarbamoyl)phenyl)sulfamoyl)phenyl pivalate | |
0.00034 | - |
pH 7.4, 30°C | Homo sapiens | sivelestat | |
0.00036 | - |
pH 7.4, 30°C | Homo sapiens | 4-(N-(2-butyrylphenyl)sulfamoyl)phenyl pivalate | |
0.00047 | - |
pH 7.4, 30°C | Homo sapiens | 4-(N-(2-acetylphenyl)sulfamoyl)phenyl pivalate | |
0.00053 | - |
pH 7.4, 30°C | Homo sapiens | (E)-4-(N-(2-(1-(hydroxyimino)methyl)phenyl)sulfamoyl)phenyl pivalate | |
0.00061 | - |
pH 7.4, 30°C | Homo sapiens | (E)-4-(N-(2-(1-(methoxyimino)ethyl)phenyl)sulfamoyl)phenyl pivalate | |
0.00061 | - |
pH 7.4, 30°C | Homo sapiens | 2-hydroxyethyl 2-(4-(pivaloyloxy)phenylsulfonamido)benzoate | |
0.00109 | - |
pH 7.4, 30°C | Homo sapiens | 4-(N-(2-propionylphenyl)sulfamoyl)phenyl pivalate | |
0.00173 | - |
pH 7.4, 30°C | Homo sapiens | (E)-4-(N-(2-(1-(hydroxyimino)butyl)phenyl)sulfamoyl)phenyl pivalate | |
0.00205 | - |
pH 7.4, 30°C | Homo sapiens | 4-(N-(2-formylphenyl)sulfamoyl)phenyl pivalate | |
0.00205 | - |
pH 7.4, 30°C | Homo sapiens | methyl 2-(4-(pivaloyloxy)benzamido)benzoate | |
0.00231 | - |
pH 7.4, 30°C | Homo sapiens | 4-(N-(2-pentanoyl phenyl)sulfamoyl)phenyl pivalate | |
0.00237 | - |
pH 7.4, 30°C | Homo sapiens | (Z)-4-(N-(2-(1-(methoxyimino)ethyl)phenyl)sulfamoyl)phenyl pivalate | |
0.0025 | - |
pH 7.4, 30°C | Homo sapiens | (E)-4-(N-(2-(1-(hydroxyimino)propyl)phenyl)sulfamoyl)phenyl pivalate | |
0.00302 | - |
pH 7.4, 30°C | Homo sapiens | ethyl 2-(4-(pivaloyloxy)benzamido)benzoate | |
0.00391 | - |
pH 7.4, 30°C | Homo sapiens | propyl 2-(4-(pivaloyloxy)benzamido)benzoate | |
0.00494 | - |
pH 7.4, 30°C | Homo sapiens | methyl 2-(4-(3,3,3-trifluoro-2,2-dimethylpropanoyloxy)phenylsulfonamide)benzoate | |
0.01 | - |
pH 7.4, 30°C | Homo sapiens | methyl 2-(4-(3,3,3-trifluoro-2,2-dimethylpropanoyloxy)benzamido)benzoate | |
0.01 | - |
pH 7.4, 30°C | Homo sapiens | ethyl 2-(4-(3,3,3-trifluoro-2,2-dimethylpropanoyloxy)benzamido)benzoate | |
0.01 | - |
pH 7.4, 30°C | Homo sapiens | propyl 2-(4-(3,3,3-trifluoro-2,2-dimethylpropanoyloxy)benzamido)benzoate | |
0.01 | - |
pH 7.4, 30°C | Homo sapiens | methyl 2-(4-pivalamidophenylsulfonamido)benzoate | |
0.01 | - |
pH 7.4, 30°C | Homo sapiens | 4-(N-(2-acetylphenyl)sulfamoyl)phenyl 2-methylpropane-2-sulfinate | |
0.01 | - |
pH 7.4, 30°C | Homo sapiens | 4-(N-(2-formylphenyl)sulfamoyl)phenyl 2-methylpropane-2-sulfinate |
General Information | Comment | Organism |
---|---|---|
malfunction | excessive release of proteases mediates tissue damage | Homo sapiens |